News
The Augurex team brings together leading scientific, clinical, technical and commercial expertise to ensure that our research translates into advanced diagnostics for improved patient outcomes.
10 Years of Peer-Reviewed Studies Predicting and Informing the Prognosis Profile of Autoimmune Patients
Recent journal publications are fortifying the clinically important role of the 14-3-3η blood test along the whole continuum of RA and autoimmune patient care. From RA meta-analysis data through to 14-3-3η expression in juvenile idiopathic arthritis and secondary...
Serum 14-3-3η A Predictor Of Secondary Sjögren’s Syndrome In SLE
Do you have a patient with Systemic Lupus Erythematosus (SLE) that you suspect may also have Sjögren’s Syndrome (SS)? With shared clinical and serological features, overlapping SS with SLE is a comorbidity that is often challenging to identify to promptly assist...
Commitment to Access, Quality and Growth through Innovation
Dynacare Launches JOINTstat® Testing in Canada Augurex is pleased to announce the launch of JOINTstat (14-3-3ƞ) testing services through Dynacare, one of Canada’s largest and most established health solution companies with a dedicated mission to support healthy lives...
Natalie Dakers: Chair of Augurex’s Board of Directors Receives 2019 Milton Wong Award
Augurex is very proud to announce that Natalie Dakers, Chair of our Board of Directors, has been awarded the 2019 Milton Wong Award. Natalie’s award is well-deserved given her outstanding leadership and notable impact on the Life Sciences ecosystem, which Augurex has...
USPTO Awards Another Patent; New Data Demonstrating 14-3-3η as a Biomarker for Monitoring Therapy Response
USPTO Awards Patent for Citrullinated 14-3-3: Expanding Augurex's Portfolio in the Diagnosis of Rheumatoid Arthritis (RA) On November 20th, 2018 the US Patent and Trademark Office (USPTO) awarded patent number 10,132,806 entitled “Antigens Derived From Citrullinated...
Augurex and Quidel at ACR
Augurex and Quidel are pleased to announce the launch of the JOINTstat® 14-3-3η RUO (research use only) ELISA. This new distribution arrangement will get 14-3-3η testing into the hands of more investigators worldwide, including key opinion leaders and pharmaceutical...
More Precise RA Patient Care; New data on the 14-3-3η blood test to help optimize treat-to-target strategies
At the annual European congress of rheumatology meeting, The European League Against Rheumatism (EULAR), taking place in Amsterdam on June 13th-16th, leading investigators from United States, Israel, and Egypt will present new data on the 14-3-3η blood test. Several...
Digital Technology Supercluster Member Spotlight
Did you miss the Digital Technology Supercluster Member Spotlight on Augurex? Read how Augurex will be working alongside Supercluster members like Telus Health, Providence Health Care, Microsoft and LifeLabs Medical Laboratory Services to advance patient-centric...
B.C.’s Most Influential Women 2018: Stem Stars
Working in STEM means that you’re innovative, you’re creative, you’re passionate, you’re clever, you’re whoever you want to be. We're so proud of our CEO Norma Biln being recognized by BC Business as a vital contributor to Women in Tech: [button...
Digital Technology Supercluster Member Spotlight
Did you miss the Digital Technology Supercluster Member Spotlight on Augurex? Read how Augurex will be working alongside Supercluster members like Telus Health, Providence Health Care, Microsoft and LifeLabs Medical Laboratory Services to advance patient-centric...
B.C.’s Most Influential Women 2018: Stem Stars
Working in STEM means that you’re innovative, you’re creative, you’re passionate, you’re clever, you’re whoever you want to be. We're so proud of our CEO Norma Biln being recognized by BC Business as a vital contributor to Women in Tech: [button...
2018 Ready to Rocket Winner
Honored to be recognized by "Ready to Rocket" as one of the 10 featured Life Sciences companies to experience accelerated growth. We're excited for the future! About Ready to Rocket: Ready to Rocket is a unique business recognition list that profiles technology...
BC-Led Digital Technology Supercluster Awarded Federal Funding to Transform Canada’s Fastest-Growing Tech Sector
As a founding member, we are thrilled that the BC-led #DigitalSupercluster has been chosen. Truly an exciting day for technology innovation in Canada!
Canada’s Most Powerful Women: Top 100 Current Winners
Augurex CEO Norma Biln was awarded Canada's Most Powerful Women: Top 100 Award for her extraordinary leadership and continued drive to inspire others. The Top 100 Award Winner community now includes 1,005 remarkable women who together celebrate accomplishments, share...
Children get arthritis too; Data on a blood test to help characterize JIA and its subtypes.
At the world’s premier arthritis conference, the American College of Rheumatology Annual Meeting (ACR), taking place in San Diego on November 3rd-8th, leading investigators from the United States, Canada and Egypt will present new data on the 14-3-3η blood test....
USPTO Issues 14-3-3η Patent: Good News for RA Patients
NEWS RELEASE | OCTOBER 17, 2017 Vancouver, BC — Augurex Life Sciences Corp is proud to announce that 14-3-3η, a novel rheumatoid arthritis (RA) biomarker, is paving a future for better patient outcomes. Today the U.S Patent and Trademark Office (USPTO) has issued...
Explaining The “Why”; 14-3-3η’s Biological Role As A Basis For Its Clinical Utility
Vancouver, BC – June 13, 2017. At the annual European congress of rheumatology meeting, The European League Against Rheumatism (EULAR), taking place in Madrid, Spain on June 14-17, investigators present the continued understanding of 14-3-3η's role in rheumatoid...
Serial 14-3-3η testing: informing RA flare and joint damage risk as you treat-to-target
Vancouver, BC – April 18, 2017. At the premier Asia-Pacific rheumatology conference, the Japan College of Rheumatology Annual Scientific Meeting (JCR), taking place in Fukuoka, Japan on April 20-22, international investigators from the United States, Canada, and...
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Home
Products
Science
About
News
Careers
Contact